Garlic Cognition Randomized Trial: What the Evidence Says

Quick Answer

Garlic Cognition Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 research article.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Nevertheless, patient adherence is often suboptimal owing to the high costs and varying degrees of adverse effects associated with long-term medication use, such as hypokalemia, bronchospasm, and angioedema. [Deshmukh Saylee (2025); evidence level 1]
• Based on an understanding of Ayurvedic pathophysiology, it may be said that EH occurs due to vitiation of(i.e., body factor responsible for movement and cognition; SAT: B.384) and(i.e., blood tissues; SAT-B.429), which cause vasoconstriction through impaired hormonal actions and lead to increased peripheral resistance. [Deshmukh Saylee (2025); evidence level 1]
• These changes likely contribute to cognitive decline, sensorimotor impairments and increased vulnerability to neurodegenerative disorders. [Mony Tamanna (2026); evidence level 4]
• There is strong evidence indicating the ability of AGE to slow the progression of atherosclerosis, thus serving as a nutraceutical in the primary prevention and mitigation of CVD and stroke. [Mony Tamanna (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For garlic cognition randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Deshmukh Saylee (2025). Effectiveness and safety of Ayurvedic intervention in essential hypertension: a systematic review with meta-analysis. DOI: 10.3389/fphar.2025.1695614. PMCID: PMC12757693. PMID: 41487502. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12757693/
• Mony Tamanna (2026). Supplementation of aged garlic extract attenuates age-associated memory impairment and cognitive decline: Involvement of molecular pathways in the cortex and hippocampus. DOI: 10.3892/br.2025.2075. PMCID: PMC12603483. PMID: 41230016. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ Creative Commons Attribution-NonCommercial-NoDerivs License This i.... https://pmc.ncbi.nlm.nih.gov/articles/PMC12603483/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.